Cost of illness and health service patterns in Morbus Parkinson in Austria;Krankheitskosten und Versorgungssituation bei Morbus Parkinson - eine Analyse in Österreich

Wiener Klinische Wochenschrift

Volumn 121, Issue 17-18, 2009, Pages 574-582

  Von Campenhausen, Sonja ^a,b   Winter, Yaroslav ^a   Gasser, Julia ^c   Seppi, Klaus ^c   Reese, Jens P ^a   Pfeiffer, Karl P ^c   Geiger Gritsch, Sabine ^d   Bötzel, Kai ^b   Siebert, Uwe ^d,e   Oertel, Wolfgang H ^a   Dodel, Richard ^a   Poewe, Werner ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Austria; Cost of illness; Health economics; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; AUSTRIA; CLINICAL ASSESSMENT TOOL; COST OF ILLNESS; DEMOGRAPHY; DEPRESSION; DRUG COST; DYSKINESIA; DYSTONIA; FEMALE; HEALTH CARE UTILIZATION; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE REGRESSION; PARKINSON DISEASE; PREVALENCE; PSYCHOSIS; RIGIDITY;

AGED; AGED, 80 AND OVER; AUSTRIA; COST OF ILLNESS; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 70450202997     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1223-6     Document Type: Article

References (21)

1. P Andlin-Sobocki B Jonsson HU Wittchen J Olesen 2005 Costs of disorders of the brain in Europe Eur J Neurol 12 Suppl 1 1 27 10.1111/j.1468-1331.2005. 01202.x 15877774
2. Parkinson's disease. World Health Organization. Online at www.who.int/inf-pr-1998/en/pr98-71.html Accessed 15 January 2009
3. P Lindgren S von Campenhausen AE Spottke U Siebert R Dodel 2005 Cost of Parkinson's disease in Europe Eur J Neurol 12 Suppl 1 68 73 10.1111/j.1468-1331. 2005.01197.x 15877783 (Pubitemid 40755608)
4. MM Hoehn M Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 5 427 442
5. C LePen S Wait F Moutard-Martin M Dujardin M Ziegler 1999 Cost of illness and disease severity in a cohort of French patients with Parkinson's disease Pharmacoeconomics 16 59 69 10.2165/00019053-199916010-00006 1:STN:280: DyaK1MzmtlKlsg%3D%3D 10539122 (Pubitemid 29330472)
6. P Hagell S Nordling J Reimer M Grabowski U Persson 2002 Resource use and costs in a Swedish cohort of patients with Parkinson's disease Mov Disord 17 1213 1220 10.1002/mds.10262 12465059 (Pubitemid 36041335)
7. L Findley M Aujla PG Bain M Baker C Beech C Bowman, et al. 2003 Direct economic impact of Parkinson's disease: a research survey in the United Kingdom Mov Disord 18 1139 1145 10.1002/mds.10507 14534917 (Pubitemid 37336937)
8. T Keranen S Kaakkola K Sotaniemi 2003 Economic burden and quality of life impairment increase with severity of PD Parkinsonism Relat Disord 9 163 168 10.1016/S1353-8020(02)00097-4 1:STN:280:DC%2BD3s%2FmsVartg%3D%3D 12573872 (Pubitemid 36173566)
9. AE Spottke M Reuter O Machat B Bornschein S von Campenhausen K Berger, et al. 2005 Cost of illness and its predictors for Parkinson's disease in Germany Pharmacoeconomics 23 817 836 10.2165/00019053-200523080-00007 16097843 (Pubitemid 41420428)
10. WR Gibb AJ Lees 1989 The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease Neuropathol Appl Neurobiol 15 27 44 10.1111/j.1365-2990.1989.tb01147.x 1:STN:280:DyaL1M3mt1Cquw%3D%3D 2542825
11. Y Winter C Wolfram O Schöffski RC Dodel T Back 2008 Langzeitkrankheitskosten 4 Jahre nach Schlaganfall oder TIA in Deutschland Nervenarzt 79 918 926 10.1007/s00115-008-2505-3 1:STN:280:DC%2BD1cvpvVygsg%3D%3D 18528673
12. HM Hamer A Spottke C Aletsee S Knake J Reis A Strzelczyk, et al. 2006 Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany Epilepsia 47 2165 2172 10.1111/j.1528-1167.2006.00889.x 17201718 (Pubitemid 44952272)
13. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease II. Macmillan, New York, p 153-163
14. Statistik Austria. Statistisches Jahrbuch 2009. www.statistik.at/web-de/ services/stat-jahrbuch/index.html Accessed 08 January 2009
15. Bundesministerium für Gesundheit und Frauen (2005) Leistungsorientierte Krankenanstaltfinanzierung. Leistungskatlog 2005. BMGF, Wien
16. JA Barber SG Thompson 2000 Analysis of cost data in randomized trials: an application of the non-parametric bootstrap Statistics In Medicine 19 3219 3236 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P 1:STN:280:DC%2BD3M3kt12kuw%3D%3D 11113956
17. Efron B, Tibshirani RJ (1993) An Introduction to the Bootstrap. Chapman and Hall, London
18. I Dengler N Leukel T Meuser WH Jost 2006 Prespektive Erfassung der direkten und indirekten Kosten des idiopathischen Parkinson-Syndroms Nervenarzt 77 1204 1209 10.1007/s00115-006-2150-7 1:STN:280:DC%2BD28nisVaisg%3D%3D 17004081 (Pubitemid 44627679)
19. K Whetten-Goldstein F Sloan E Kulas, et al. 1997 The burden of Parkinson's disease on society, family, and the individual J Am Geriatr Soc 45 7 844 849 1:STN:280:DyaK2szlvVaitA%3D%3D 9215336
20. DM Huse K Schulman L Orsini J Castelli-Haley S Kennedy G Lenhart 2005 Burden of illness in Parkinson's disease Mov Disord 20 11 1449 1454 10.1002/mds.20609 16007641 (Pubitemid 43072653)
21. ER Dorsey R Constantinescu JP Thompson KM Biglan RG Holloway K Kieburtz, et al. 2007 Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 68 5 384 386 10.1212/01.wnl. 0000247740.47667.03 1:STN:280:DC%2BD2s%2FlsFOmug%3D%3D 17082464 (Pubitemid 46184217)